1. Home
  2. PFBC vs DRTS Comparison

PFBC vs DRTS Comparison

Compare PFBC & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Preferred Bank

PFBC

Preferred Bank

HOLD

Current Price

$107.70

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$14.21

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFBC
DRTS
Founded
1991
2015
Country
United States
Israel
Employees
324
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PFBC
DRTS
Price
$107.70
$14.21
Analyst Decision
Hold
Strong Buy
Analyst Count
3
3
Target Price
$102.67
$8.67
AVG Volume (30 Days)
94.8K
569.0K
Earning Date
04-22-2026
05-18-2026
Dividend Yield
3.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.94
N/A
Revenue Next Year
$8.31
$699.98
P/E Ratio
$8.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$81.50
$3.01
52 Week High
$112.26
$14.75

Technical Indicators

Market Signals
Indicator
PFBC
DRTS
Relative Strength Index (RSI) 60.00 61.69
Support Level $99.20 $6.59
Resistance Level $109.99 N/A
Average True Range (ATR) 2.15 0.72
MACD 0.10 0.14
Stochastic Oscillator 87.30 84.43

Price Performance

Historical Comparison
PFBC
DRTS

About PFBC Preferred Bank

Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking, which include Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: